Peripheral Neuritis Treatment Industry Revenue to Reach $2.44 Billion by 2030 with CAGR of 4.8% (2026-2030)

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.


What Is the Forecasted Market Size of the Peripheral Neuritis Treatment Market by 2030?
The peripheral neuritis treatment market size has grown strongly in recent years. It will grow from $1.93 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to high prevalence of diabetic neuropathy, limited availability of targeted therapies, reliance on conventional analgesics and anticonvulsants, growing awareness of peripheral neuritis symptoms, fragmented healthcare infrastructure.

The peripheral neuritis treatment market size is expected to see steady growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to advancements in pharmacological therapies, increasing adoption of non-pharmacological therapies such as tens and acupuncture, rising use of online and retail pharmacies, growing focus on lifestyle and dietary modifications, expansion of diabetic care programs and specialized clinics. Major trends in the forecast period include increasing adoption of ai-based peripheral neuritis monitoring tools, rising integration of digital health platforms for peripheral neuropathy management, growing use of genomic and precision medicine approaches in peripheral neuritis, increasing implementation of iot-enabled patient monitoring devices, rising development of smart manufacturing for peripheral neuritis therapeutics.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21254&type=smp

What Are the Key Drivers of the Peripheral Neuritis Treatment Market?
The rising prevalence of diabetes is expected to propel the growth of the peripheral neuritis treatment market going forward. Diabetes is a chronic medical condition that occurs when the body is unable to properly regulate blood sugar (glucose) levels. The rising prevalence of diabetes is due to factors such as sedentary lifestyles, unhealthy diets, obesity, aging populations, and genetic predisposition. Peripheral neuritis treatment supports diabetic individuals by relieving nerve pain, reducing inflammation, and enhancing nerve function, helping to improve their quality of life and prevent complications. For instance, in 2024, according to the International Diabetes Federation, a Belgium-based diabetes research organization, published that the number of adults aged 20 to 79 years living with diabetes worldwide is projected to increase significantly from about 589 million in 2024 to 853 million by 2050, representing a 45% increase. Therefore, the rising prevalence of diabetes is driving the growth of the peripheral neuritis treatment market.

What Segments Are Covered in the Peripheral Neuritis Treatment Market Report?
The peripheral neuritis treatment market covered in this report is segmented –

1) By Treatment Type: Pharmacological Therapies, Non Pharmacological Therapies
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
3) By Application: Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Other Applications

Subsegments:
1) By Pharmacological Therapies: Pain Relievers (Analgesics), Antidepressants, Anticonvulsants, Topical Medications
2) By Non-Pharmacological Therapies: Physical Therapy, Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture, Lifestyle And Dietary Modifications

Which Trends Are Positively Affecting the Peripheral Neuritis Treatment Market Expansion?
Major companies in the peripheral neuritis treatment market are focusing on the development of innovative treatments such as magnetic peripheral nerve stimulation (mPNS) treatment to enhance nerve regeneration and reduce neuropathic pain. Magnetic peripheral nerve stimulation (mPNS) treatment refers to a non-invasive neuromodulation technique that uses magnetic fields to stimulate peripheral nerves, helping to manage pain, enhance nerve regeneration, and improve motor function in conditions such as neuropathy and musculoskeletal disorders. For instance, in January 2024, Neuralace Medical Inc., a US-based medical equipment manufacturing company, announced Axon Therapy (mPNS), for the treatment of chronic painful diabetic neuropathy (PDN), approved by the Food and Drug Administration, a US-based government agency. This therapy provides a quick, painless, and noninvasive approach to pain relief. Clinical trials demonstrated a 72.3% responder rate at Day 30 and an 81.4% responder rate at Day 90, highlighting its effectiveness in reducing pain and numbness. This approval marks a significant advancement in pain management, offering patients an alternative to traditional treatments without the side effects of medication.

What Are the Top Companies to Watch in the Peripheral Neuritis Treatment Market?
Major companies operating in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.

Get the full peripheral neuritis treatment market report here:
https://www.thebusinessresearchcompany.com/report/peripheral-neuritis-treatment-global-market-report

Which Region Is Expected to Lead the Peripheral Neuritis Treatment Market by 2030?
North America was the largest region in the peripheral neuritis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. How has the ammonia grown historically, and what trends indicate future expansion? The ammonia market size has grown strongly in recent years. It will grow from $79.13 billion in 2024 to $85.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to agricultural demand, expanding population, energy and power generation, chemical manufacturing:. The ammonia market size is expected to see strong growth in the next few years. It will grow to $124.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to hydrogen economy development, renewable energy, carbon capture and storage (ccs), clean energy transition. Major trends in the forecast period includ...
Read more

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the poultry disinfectant industry by 2029? The poultry disinfectant market size has grown strongly in recent years. It will grow from $4.67 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to demand for biosecurity and disease prevention, growth in poultry farming and agriculture, expansion of food safety regulations, use in hatcheries and broiler farms, regulatory standards for poultry hygiene. The poultry disinfectant market size is expected to see rapid growth in the next few years. It will grow to $7.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to sustainable and eco-frie...
Read more

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Ammonium Sulfate industry. What is the projected value of the ammonium sulfate market by 2029? The ammonium sulfate market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to economic growth, agriculture demand, government subsidies, population growth, rise in chemical industry. The ammonium sulfate market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing crop yields, environmental regulations, food security concerns, rising pharmaceuticals sector, rise in disposable income. Major ...
Read more